JMP Securities Reiterates Market Outperform on Zimmer Biomet Holdings, Maintains $160 Price Target
Portfolio Pulse from richadhand@benzinga.com
JMP Securities analyst David Turkaly has reiterated a Market Outperform rating on Zimmer Biomet Holdings (NYSE:ZBH) and maintained a $160 price target.
August 04, 2023 | 11:23 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Zimmer Biomet Holdings has been reiterated with a Market Outperform rating and a $160 price target by JMP Securities.
The reiteration of a Market Outperform rating and a maintained price target of $160 by JMP Securities indicates a positive outlook for Zimmer Biomet Holdings. This could potentially lead to an increase in investor confidence and a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100